PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 18, 2017European Heart Journal160 citationsOpen Access

Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST)

View Full Paper
GHGerhard HindricksNVNiraj VarmaSKSalem Kacet

Structured PICO

Does daily remote monitoring reduce mortality and heart failure hospitalization in patients with implantable cardioverter-defibrillators?

P
Population
Patients with implantable cardioverter-defibrillators (pooled patient-level data from 3 RCTs: IN-TIME, ECOST, TRUST)
I
Intervention
Daily remote monitoring (HM)
O
Outcome
All-cause mortality and the composite endpoint of all-cause mortality or worsening heart failure (WHF) hospitalizationcomposite

Daily remote monitoring of ICDs reduces all-cause mortality and heart failure hospitalizations, likely driven by the prevention of heart failure exacerbations.

Abstract

In a pooled analysis of the three trials, HM reduced all-cause mortality and the composite endpoint of all-cause mortality or WHF hospitalization. The similar magnitudes of absolute risk reductions for WHF and CV endpoints suggest that the benefit of HM is driven by the prevention of heart failure exacerbation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hindricks et al. (2017) studied this question.

synapsesocial.com/papers/69dbb1ea4e9a02dbaa6857a6https://doi.org/10.1093/eurheartj/ehx015
Ask AI
Helpful
Bookmark
Share
View Full Paper